Fecal microbiota transplantation for recurrent Clostridium difficile infection in children

https://doi.org/10.1016/S0163-4453(17)30202-5Get rights and content

Summary

Fecal microbiota transplantation (FMT) is a relatively simple, promising treatment for recurrent Clostridium difficile infection. While there are a wide variety of approaches including mode of delivery, the results are nonetheless encouraging, even amongst younger children. Experience with FMT in the pediatric population is increasing, showing similar success compared to adults. This article will provide an overview of C. difficile infection along with review of the rationale, methods and complications of FMT including the current experience of FMT in children.

References (0)

Cited by (17)

  • The Development of Early Life Microbiota in Human Health and Disease

    2022, Engineering
    Citation Excerpt :

    Fecal microbiota transplantation (FMT) is a well-tolerated, simple, and promising treatment for pediatric diseases. FMT has been performed to treat pediatric diseases such as ASD [223], IBD [224], Clostridium difficile infection [225], and refractory diarrhea [226]. In line with findings in adults, the symptoms of two-year-old children with Clostridium difficile infection were relieved by FMT and showed no recurrence within six months of follow-up [225].

  • Clostridium difficile Infection in Children

    2019, Advances in Pediatrics
    Citation Excerpt :

    However, it has not been shown that the route affects the efficacy of FMT. Adverse events are uncommon, and include gastrointestinal symptoms (eg, nausea, vomiting, flatulence, bloating, abdominal and/or rectal discomfort), headaches, and transient fever [67–69]. There are no published RCTs in children and the experience, although limited, is increasing.

  • Therapeutic Contraindications in Exotic Pets

    2018, Veterinary Clinics of North America - Exotic Animal Practice
    Citation Excerpt :

    Metronidazole (20 mg/kg orally or IV every 12 h) can be administered for clostridial overgrowth and has been reported to reduce the number of mortalities associated with enterotoxemia.66 The re-establishment of normal colonic microbiome through fecal microbiota transplantation has an inhibitory effect against pathogenic bacteria and is now considered a standard treatment of recurrent C difficile infections in humans.67 Based on this principle, anecdotal reports of transfaunation with cecotrophes from a healthy conspecific show that this treatment may be of benefit in rabbits with antibiotic-associated dysbiosis.68

  • Faecal microbiota transplantation in children: A systematic review

    2024, Acta Paediatrica, International Journal of Paediatrics
View all citing articles on Scopus
View full text